Literature DB >> 35846532

Epstein-Barr virus infection presenting as encephalitis in HIV-Phenomenon not seen frequently.

Rahul Mahajan1, Kuljeet Singh Anand1, Abhishek Juneja1, Jyoti Garg1.   

Abstract

Epstein-Barr virus (EBV) infection can rarely present as encephalitis in HIV patients. We report a case of a 22-year-old female patient, diagnosed to have HIV infection 8 years back. She presented with headache and altered behavior for a week and focal fits for 2 days. Neurological examination was unremarkable. Cerebrospinal fluid (CSF) examination revealed lymphocytic pleocytosis with raised protein. EBV was detected in CSF using polymerase chain reaction test. Magnetic resonance imaging of the brain revealed T2/fluid-attenuated inversion recovery hyperintensities involving the left frontal cortex, left thalamus, and right medial temporal cortex. The patient was started on antiviral therapy considering the diagnosis of EBV encephalitis. The patient completely recovered over the next few weeks. Copyright:
© 2022 Indian Journal of Sexually Transmitted Diseases and AIDS.

Entities:  

Keywords:  Encephalitis; Epstein-Barr virus; HIV

Year:  2022        PMID: 35846532      PMCID: PMC9282698          DOI: 10.4103/ijstd.IJSTD_91_19

Source DB:  PubMed          Journal:  Indian J Sex Transm Dis AIDS        ISSN: 2589-0557


Introduction

Patients with HIV infection are at higher risk of developing herpes central nervous system (CNS) infections. Among herpes viruses, cytomegalovirus, herpes simplex, and Epstein-Barr virus (EBV) are known to cause CNS infections in HIV-positive patients.[1] EBV is a B-lymphotropic virus that is associated with a variety of lymphoid malignancies in immunocompromised patients, including primary CNS and Burkitt's Lymphoma.[2] Rarely, it can also present as meningitis, encephalitis, transverse myelitis, and peripheral neuropathies.[3]

Case Report

We report a case of a 22-year-oldfemale patient, diagnosed to have HIV infection 8 years back. She was on antiretroviral therapy (ART) for the last 8 years. The patient had not been taking ART regularly for the last 2 years. Her CD4 count had gradually fallen to 238/mm3 from 520/mm3 over 2 years. She presented to us with complaints of headache and altered behavior for a week and focal fits for 2 days. She had holocranial, throbbing headache associated with episodes of vomiting. She was irritable and showed no interest in her surroundings. The mother found her muttering to herself for the last few days. She was scared and believed that someone wanted to kill her. Later, she had multiple fits in the form of right-sided facial twitching and clonic jerky movements of the right upper limb. There was no history of fever, neck pain, or loss of consciousness. Neurological examination was unremarkable. Her routine blood investigations were normal. CD4 count was 238/mm3. Cerebrospinal fluid (CSF) examination revealed total cell count of 30/mm3 with lymphocytic predominance. CSF protein was 68 mg/dl, while sugar was 72 mg/dl. On further testing, EBV was detected using polymerase chain reaction (PCR) test. While tuberculosis PCR, virology (including herpes simplex, varicella-zoster, cytomegalovirus, and JC virus), syphilis, toxoplasma serology, cryptococcal antigen, bacterial, and fungal cultures were negative in blood and CSF. The quantitative viral assay showed a high level of EBV in CSF (42,864 copies/ml). Magnetic resonance imaging of the brain revealed T2/fluid-attenuated inversion recovery hyperintensities involving the left frontal cortex left thalamus and right medial temporal cortex [Figures 1 and 2]. The patient was started on antiviral therapy with valganciclovir considering the diagnosis of EBV encephalitis. The patient completely recovered over the next few weeks. She was discharged on antiepileptic and ART.
Figure 1

T2 fluid-attenuated inversion recovery sequence of magnetic resonance imaging brain showing hyperintensity in the left frontal cortex

Figure 2

T2 fluid-attenuated inversion recovery sequence of magnetic resonance imaging brain showing hyperintensity in the left thalamus

T2 fluid-attenuated inversion recovery sequence of magnetic resonance imaging brain showing hyperintensity in the left frontal cortex T2 fluid-attenuated inversion recovery sequence of magnetic resonance imaging brain showing hyperintensity in the left thalamus

Discussion

Viral encephalitis in HIV-infected patients can be due to HIV per se and various other opportunistic pathogens. Cytomegalovirus and herpes simplex are the commonest viral infections of the CNS in HIV.[4] EBV infection can present as meningitis, encephalitis, and myelitis. These neurological complications usually occur after few weeks of the onset of acute infectious mononucleosis. EBV encephalitis has been reported in literature mainly in immunocompromised patients.[5] Rarely, neurological symptoms occur in the absence of systemic involvement as in our patient. Various hypotheses including infiltration of CD8 + T-cells into the neural tissue and deposition of antigen-antibody complexes in the endothelial tissue have been proposed.[6] CSF PCR has been reported to be a useful quantitative test for diagnosing EBV-associated CNS disease.[7] It has a sensitivity of 80%.[7] Formal guidelines exist for the management of Herpes-simplex, cytomegalovirus, and Varicella-zoster-related encephalitis but not for EBV-associated encephalitis.[4] Ganciclovir and valganciclovir have been shown to reduce EBV viremia. There are reports of successful treatment of EBV-encephalitis with both these antiviral drugs.[89] Our case highlights EBV as opportunistic infection in HIV-infected patients which may occur at relatively high CD4 counts.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

1.  (Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.

Authors:  Britta Höcker; Stephan Böhm; Helmut Fickenscher; Uta Küsters; Paul Schnitzler; Martin Pohl; Ulrike John; Markus J Kemper; Henry Fehrenbach; Marianne Wigger; Martin Holder; Monika Schröder; Reinhard Feneberg; Sabine Köpf-Shakib; Burkhard Tönshoff
Journal:  Transpl Int       Date:  2012-04-25       Impact factor: 3.782

2.  Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system.

Authors:  Adriana Weinberg; Shaobing Li; Megan Palmer; Kenneth L Tyler
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

3.  Unusual presentation of Epstein-Barr virus hepatitis treated successfully with valganciclovir.

Authors:  Katrine Cauldwell; Roger Williams
Journal:  J Med Virol       Date:  2013-09-30       Impact factor: 2.327

Review 4.  Infection with Epstein-Barr virus and cancer: an epidemiological review.

Authors:  D Serraino; P Piselli; C l Angeletti; M Scuderi; G Ippolito; M R Capobianchi
Journal:  J Biol Regul Homeost Agents       Date:  2005 Jan-Jun       Impact factor: 1.711

Review 5.  Viral meningoencephalitis: a review of diagnostic methods and guidelines for management.

Authors:  I Steiner; H Budka; A Chaudhuri; M Koskiniemi; K Sainio; O Salonen; P G E Kennedy
Journal:  Eur J Neurol       Date:  2010-03-03       Impact factor: 6.089

6.  Epstein-Barr virus infections of the central nervous system.

Authors:  Hiroshi Fujimoto; Kyoko Asaoka; Toshihiro Imaizumi; Mitsuyoshi Ayabe; Hiroshi Shoji; Masahide Kaji
Journal:  Intern Med       Date:  2003-01       Impact factor: 1.271

7.  Rapidly progressive and fatal EBV-related encephalitis in a patient with advanced HIV-1 infection at presentation: a case report and review of the literature.

Authors:  Ennio Polilli; Federica Sozio; Elena Mazzotta; Augusta Consorte; Francesco Di Masi; Adriana Agostinone; Monica Tontodonati; Luana Cosentino; Giustino Parruti
Journal:  New Microbiol       Date:  2010-07       Impact factor: 2.479

8.  The effect of highly active antiretroviral therapy on outcome of central nervous system herpesviruses infection in Cuban human immunodeficiency virus-infected individuals.

Authors:  Pedro Ariel Martínez; René Díaz; Daniel González; Lisset Oropesa; Ruby González; Lissette Pérez; Jenniffer Viera; Vivian Kourí
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

Review 9.  Neurologic complications of infectious mononucleosis.

Authors:  K P Connelly; L D DeWitt
Journal:  Pediatr Neurol       Date:  1994-05       Impact factor: 3.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.